World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
73
Citations
15710
World Ranking
1699
National Ranking
728

John L. Johnson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where John L. Johnson sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 254 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

John L. Johnson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where John L. Johnson sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

John L. Johnson is affiliated with Case Western Reserve University in the United States. Their research primarily spans the field of Medicine, with a focus on Infectious Diseases, Epidemiology, Immunology, Surgery, and Molecular Biology. The scientist's work encompasses several specific topics including Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Pneumonia and Respiratory Infections, Pneumocystis jirovecii pneumonia detection and treatment, Immune Cell Function and Interaction, Immunodeficiency and Autoimmune Disorders, and Advanced materials and composites.

Their recent publications include:

  • Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses (2021, Immunity)
  • Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis (2021, New England Journal of Medicine)
  • High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial (2020, Contemporary Clinical Trials)
  • The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2 (2022, Proceedings of the National Academy of Sciences)
  • Effects of BCG vaccination on donor unrestricted T cells in two prospective cohort studies (2022, EBioMedicine)

Frequent coauthors collaborating with John L. Johnson include:

  • Susan E. Dorman
  • Kelly E. Dooley
  • Payam Nahid
  • Ekaterina V. Kurbatova
  • Patrick Phillips

The scientist often publishes in venues such as:

  • International Journal of Refractory Metals and Hard Materials
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Canadian Journal of Medicine
  • Nature Communications
  • Clinical Infectious Diseases

Best Publications

  • A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus

    Whalen Cc;Johnson Jl;Okwera A;Hom Dl

  • Similarity Analysis of DNAs

    John L. Johnson;William B. Whitman

  • Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.

    Susan E. Dorman;Payam Nahid;Ekaterina V. Kurbatova;Patrick P.J. Phillips

  • Depressed T-Cell Interferon-γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy

    Christina S. Hirsch;Zahra Toossi;Catherine Othieno;John L Johnson

  • A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.

    Marjorie Z. Imperial;Payam Nahid;Patrick P. J. Phillips;Geraint R. Davies

  • Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

    John L. Johnson;D. J. Hadad;W. H. Boom;C. L. Daley

  • Emendation of Bacteroidaceae and Butyrivibrio and Descriptions of Desulfomonas gen. nov. and Ten New Species in the Genera Desulfomonas, Butyrivibrio, Eubacterium, Clostridium, and Ruminococcus

    W. E. C Moore;J. L. Johnson;L. V. Holdeman

  • A study of the safety immunology virology and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis.

    Robert S. Wallis;Peter Kyambadde;John L. Johnson;Libby Horter

  • Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

    Christopher C. Whalen;Peter Nsubuga;Alphonse Okwera;John L. Johnson

  • Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis.

    Moises Palaci;Reynaldo Dietze;David Jamil Hadad;Fabiola Karla Corrêa Ribeiro

  • Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.

    Thomas J Scriba;Adam Penn-Nicholson;Smitha Shankar;Tom Hraha

  • Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis

    Charles A. Peloquin;David Jamil Hadad;Lucilia Pereira Dutra Molino;Moises Palaci

  • Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma

    Unknown

  • Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.

    John L. Johnson;Alphonse Okwera;David L. Hom;Harriet Mayanja

  • Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis.

    Reynaldo Dietze;David Jamil Hadad;Bryan McGee;Lucilia Pereira Dutra Molino

  • Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.

    L Teixeira;M D Perkins;J L Johnson;R Keller

  • Bacteroides intermedius comb. nov. and Descriptions of Bacteroides corporis sp. nov. and Bacteroides levii sp. nov.

    John L. Johnson;Lillian V. Holdeman

  • Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations

    Marc H Weiner;Charles Peloquin;William Burman;Chi Cheng Luo

  • Apoptosis and T Cell Hyporesponsiveness in Pulmonary Tuberculosis

    Christina S. Hirsch;Zahra Toossi;Guido Vanham;John L. Johnson

  • Drug Tolerance in Mycobacterium tuberculosis

    Robert S. Wallis;Shripad Patil;Seon Hee Cheon;Seon Hee Cheon;Kay Edmonds

  • Augmentation of Apoptosis and Interferon-γ Production at Sites of Active Mycobacterium tuberculosis Infection in Human Tuberculosis

    C. S. Hirsch;Z. Toossi;J. L. Johnson;H. Luzze

  • Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans

    A. Okwera;F. Byekwaso;R. Mugerwa;J. Ellner

  • A Randomized, Double-Blind, Placebo-Controlled Trial of the Use of Prednisolone as an Adjunct to Treatment in HIV-1—Associated Pleural Tuberculosis

    Alison M. Elliott;Henry Luzze;Maria A. Quigley;Jessica S. Nakiyingi

Frequent Co-Authors

Jerrold J. Ellner
Jerrold J. Ellner Rutgers, The State University of New Jersey
Moses Joloba
Moses Joloba Makerere University
Robert S. Wallis
Robert S. Wallis Aurum Institute
W. Henry Boom
W. Henry Boom Case Western Reserve University
Zahra Toossi
Zahra Toossi Case Western Reserve University
John T. Belisle
John T. Belisle Colorado State University
David M. Lewinsohn
David M. Lewinsohn Oregon Health & Science University
Willem A. Hanekom
Willem A. Hanekom University College London
Thomas J. Scriba
Thomas J. Scriba University of Cape Town
Peter Mugyenyi
Peter Mugyenyi Uganda National Academy of Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology in the USA opens doors to several related online degrees and career options. For those interested in advancing their education in health sciences, numerous medical degrees online offer flexible learning paths designed to accommodate busy schedules and diverse backgrounds.

Public health is another complementary field, where obtaining a Master of Public Health (MPH) can enhance your career prospects. Many students seek best easiest mph online programs to get into that balance accessibility with quality education, making it easier to launch or progress a career in community health and disease prevention.

For those passionate about working directly with vulnerable populations, becoming a child life specialist is a rewarding option. Individuals with a bachelor's degree can explore this path, which offers a meaningful impact and competitive salary, as detailed in the guide on child life specialist salary with bachelor degree.

Inclusivity in education is crucial, and if you have a criminal record, don’t be discouraged. Many reputable institutions welcome diverse applicants through online colleges that accept felons, providing valuable opportunities to earn degrees in microbiology and related fields.

Best Scientists Citing John L. Johnson

Trending Scientists

Recently Published Articles